Pharmafile Logo

Making at Impact at the Alliance Industry Summit

- PMLiVE

The Medscape team will be returning to the Alliance Industry Summit in Philadelphia this year, bringing with them Best in Class Outcomes and support for the event. As part of their dedication to and leadership in the continuing education in the health professions community, Medscape is proud to act as a silver sponsor of the AIS event.

“We look forward to the Alliance Industry Summit every year, and we’re pleased to be a silver sponsor for 2024. The conference is a great opportunity to connect with our education colleagues from across the country to share best practices and collaborate on ways to move the industry forward,” said Laura Gaskell, Senior Marketing Director. “We’re particularly excited to be bringing with us a poster for the Best in Class Outcomes reception. Our programs have produced valuable real-world outcomes and insights that prove the power of education, and we’re looking forward to sharing them.”

Medscape’s poster, “Real-World Outcomes in Alzheimer’s Disease,” will be available during the Best in Class reception on Monday, September 16, from 5:30-6:30PM. Katie Lucero, PhD, Chief Impact Officer, will be available during the session to discuss the poster and Medscape’s education impact.

For more information on Medscape’s activities during AIS, please contact Laura Gaskell at LGaskell@Medscape.net.

This content was provided by Medscape Education

Company Details

 Latest Content from  Medscape Education 

Medscape Education Demonstrates Deep Cardiology Outcomes Expertise at ACC 2023

As cardiologists from around the world return home from New Orleans and ACC 2023, Medscape Education is looking back at a successful conference.At this year’s event, the Medscape Education team...

Rare Diseases on Medscape Education: Pustular Psoriasis

Rare Disease Day may be over but our committment to advancing outcomes for patients continues. Watch this video to understand a patient's journey with pustular psoriasis.To learn more about Medscape's rare...

Rare Diseases on Medscape Education: Long-Chain Fatty Acid Oxidation Disorder

Rare Disease Day may be over but our committment to advancing outcomes for patients continues. Listen to a mother explain her daughter's journey with a long-chain fatty acid oxidation disorder.To...

Medscape Expands Global Reach with Acquisition of Health Information Platform Grupo SANED

WebMD Health Corp., an Internet Brands company and a leader in health information services for physicians, other healthcare professionals and consumers, today announced that it has acquired Grupo SANED, Spain's leader in...

Medscape Oncology: Delivering Impact at ASH

You can read more information on Medscape Oncology at ASH here, or please reach out to Chris Carey or Steve Dunn who can tell you more about how Medscape can help to...

Medscape Oncology: Delivering Impact at ASH

Medscape Oncology was on-site in New Orleans at ASH 2022. During the 4-day conference, Medscape Oncology hosted educational symposia, interacted with clinicians at our booth, and worked with leading faculty...

Medscape Education: Rare Diseases PAH

Today is Rare Disease Day, February 28.Hear from Helen as she describes in her own words what it’s like to live with PAH, and her perspective as a patient.  To learn...

Medscape Education and M4RD: Together Caring for Rare Disease

We are excited to finally share our news-style video ' ', developed in partnership with Medics 4 Rare Diseases (M4RD) and produced by Genetic Alliance UK and ITN Business.For more information on...

The Need for and Impact of Rare Disease Education

Physicians are often told that when they hear hoofbeats, think horses, not zebras — to look for the most common cause of a patient’s symptoms first. While this advice may...

Medscape Education: Rare Diseases Fibrodysplasia Ossificans Progressiva

Rare Disease Day is on February 28.Listen to Nicky explain her daughter's journey with fibrodysplasia ossificans progressiva.Many patients face long waits for accurate diagnosis and treatment, making it critically important...